Clinical Trial Update: Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France

View source ↗

Summary

A completed clinical trial evaluating the XIENCE V endoprothesis for LPPR indications in French patients with coronary artery disease, with a two-year follow-up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• XIENCE V Endoprothesis (Everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | Status: COMPLETED